In the BioHarmony Drug Report Database
Ganirelix
Ganirelix Acetate, Orgalutran (ganirelix acetate) is a protein pharmaceutical. Ganirelix acetate was first approved as Ganirelix Acetate on 1999-07-29. It is used to treat ovarian hyperstimulation syndrome in the USA. It has been approved in Europe to treat assisted reproductive techniques and ovulation induction. It is known to target gonadotropin-releasing hormone receptor.
Trade Name
|
Orgalutran |
|---|---|
Common Name
|
ganirelix acetate |
ChEMBL ID
|
CHEMBL1251 |
Indication
|
assisted reproductive techniques, ovarian hyperstimulation syndrome, ovulation induction |
Drug Class
|
Hormone-release inhibiting peptides |
Image (chem structure or protein)